Poultry Healthcare Global Market Report 2024

Poultry healthcare encompasses services that provide healthcare solutions for domesticated birds such as chickens, turkeys, ducks, geese, quails, and others. These services involve managing various aspects of poultry health, including the elimination of sick birds, timely vaccinations, and the overall management of healthcare resources. Poultry management practices, such as ensuring cleanliness, proper feeding and feed supply, and appropriate housing, are also integral components of poultry healthcare.

The poultry healthcare market covered in this report is segmented by product into vaccines, parasiticides, anti-infectives, and medical feed additives. Vaccines play a crucial role in protecting farm animals by preventing or reducing the incidence of diseases, thereby lowering the risk of disease spread. Parasiticides target infectious parasites by either destroying them or inhibiting their growth. Anti-infectives, including antibacterials, antivirals, and antifungals, are medications designed to prevent or treat infections in livestock. Medical feed additives refer to extra nutrients or drugs added to livestock feed. The market is further divided into tests, which include ELISA, PCR, molecular diagnostic tests, and laboratory tests. In terms of application, the market is segmented into farm-based and house-based practices.

The poultry healthcare research report is one of a series of new reports that provides poultry healthcare statistics, including global poultry healthcare industry size, regional shares, competitors with poultry healthcare market share, detailed poultry healthcare market segments, market trends and opportunities, and any further data you may need to thrive in the poultry healthcare industry. This poultry healthcare research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The poultry healthcare market size has grown rapidly in recent years. It will grow from $7.67 billion in 2023 to $8.51 billion in 2024 at a compound annual growth rate (CAGR) of 11.0%. The growth observed in the historical period can be attributed to several factors, including disease outbreaks affecting poultry, a rise in poultry production, the globalization of poultry trade, and increased attention to regulatory compliance within the industry.

The poultry healthcare market size is expected to see rapid growth in the next few years. It will grow to $12.55 billion in 2028 at a compound annual growth rate (CAGR) of 10.2%. The anticipated growth in the forecast period can be attributed to factors such as the increasing global consumption of poultry, a growing emphasis on preventive healthcare in the poultry industry, environmental concerns, the integration of digital technologies, and heightened consumer awareness and demand. Key trends expected during this period include the integration of technology in poultry healthcare, enhanced biosecurity measures, the implementation of customized nutrition programs, global collaboration for disease surveillance, the adoption of digital health records, and market consolidation within the poultry healthcare sector.

The growth of the poultry healthcare market is expected to be driven by the increasing prevalence of disease outbreaks in poultry animals. The World Organization for Animal Health reported that over the last six months leading up to November 2021, more than 40 countries reported various subtypes of high pathogenicity avian influenza. Confirming outbreaks in poultry and wild birds, the data indicated that since May 1, 2021, high pathogenicity avian influenza (HPAI) cases were confirmed in 41 countries. In October alone, around 16,000 cases of HPAI in domestic and wild birds were reported. Consequently, the rising incidence of disease outbreaks is a significant factor propelling the growth of the poultry healthcare market.

The growth of the poultry healthcare market is further anticipated to be fueled by the increasing consumption of poultry. Poultry, encompassing birds like chickens, turkeys, ducks, geese, and quail, is bred for meat and egg production. With a surge in the demand for poultry products, larger flocks are raised, resulting in higher disease risks due to crowded conditions. Prioritizing poultry healthcare becomes crucial to effectively prevent, control, and manage diseases. According to the USDA Economic Research Service in June 2023, the poultry sector witnessed total sales of $76.9 billion, marking a substantial 67% increase compared to 2021. Significant increases were observed in broiler sales (60%), turkey sales (21%), and egg sales (122%) compared to 2021. Hence, the growing consumption of poultry is expected to drive the growth of the poultry healthcare market.

Major companies are introducing innovative vaccines, such as recombinant vector vaccines, to gain a competitive advantage. These vaccines are specifically designed to provide robust protection against viruses like Marek's disease, infectious bursal disease, and Newcastle disease at an early stage. Zoetis US, a prominent animal health company, expanded its line of recombinant vector vaccines in January 2021 with the introduction of Poulvac Procerta HVT-IBD. This vaccine offers early protection against Marek's disease and infectious bursal disease in chickens, making it a valuable tool in the poultry industry's fight against costly viral challenges.

Major players in the poultry healthcare sector are focusing on the development of innovative healthcare products. Innovative solutions like advanced animal wound care products aim to promote faster and more effective healing in animals. For example, in March 2021, Axio Solutions, an India-based deep-science medical technology company, launched SureKlot, an advanced range of wound care products for poultry and other animals. Leveraging proven technology, these products effectively stop uncontrollable bleeding, decontaminate wounds, and enhance the overall wound healing process in animals, providing a comfortable experience without causing pain during removal.

In July 2022, Wilbur-Ellis Nutrition, a US-based company offering products and solutions for the animal nutrition and feed industries, acquired F. L. Emmert for an undisclosed amount. This strategic acquisition aligns with Wilbur-Ellis Nutrition's priorities and enhances its core businesses, covering pet, livestock, and aquaculture solutions. F. L. Emmert, a US-based company, specializes in providing high-performance ingredients for both pet food and livestock feeds.

Major companies operating in the in the poultry healthcare market report are Ceva Polchem Pvt. Ltd., Zoetis Inc., Venky's Ltd., Phibro Animal Health Corporation, Merck & Co Inc., C. H. Boehringer Sohn AG & Co. KG, Hester Biosciences Limited, Romvac Company S. A., Eli Lilly and Company, Bayer AG, Indovax Pvt. Ltd., Affini Technology Limited, Bimeda Inc., IndexxLaboratories Inc., BioChek B. V., BioinGentech, Bioneer Corporation, MEGACOR Handel mit Medizintechnik u Diagnostika GmbH, Thermo Fisher Scientific Inc., Provet Pharma Private Limited, Anitox Corp., Aviagen Inc., Cobb-Vantress Inc., Hendrix Genetics BV, Hubbard LLC, Hy-Line International, Novogen, Donald McQueen Shaver OC, Lohmann Tierzucht, Romer Labs Pte Ltd.

North America was the largest region in the poultry healthcare market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the poultry healthcare market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the poultry healthcare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The poultry healthcare market includes revenues earned by entities by enhancing meat and egg productivity and avoiding rickets, rickets, and lameness. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified)).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.